Molecular Stethoscope Raises $8.2M

San Diego-based Molecular Stethoscope, a biotechnology startup developing a blood-based, liquid biopsy platform for early detection and monitoring of disease, has raised $8.2M in a seed funding round. The funding came from Data Collective, Pfizer, Index Ventures, an un-named research university, and angels. The company said it is initially targeting its testing for diagnosing cardiometabolic and neurodegenerative diseases. Molecular Stethoscope is led by President and CEO Tina S. Nova, Ph.D. More information »